According to the guidelines, AstraZeneca could be administered to a specific age group of men and women. The vaccine shot could be given to the male aged 18 years or above, and the women above 40 years of age.
It said it was "carefully reviewing" similar instances in Australia.
Researchers may have found an explanation for the rare but serious blood clots reported among some people who received AstraZeneca's COVID-19 vaccine
"Pakistan will receive overall 45 million COVID-19 vaccine doses under the COVAX scheme this year," according to the statement.
According to sources, AstraZeneca has applied for registration to the Drug Regulatory Authority of Pakistan (DRAP) through a Pakistani pharmaceutical company, sources said.